News

FDA Approves OTC Opioid Overdose Treatment

August 03, 2023

The nasal-spray drug can be used to reverse the effects of opioid overdose.

Testing Innovative Analytical Waters

August 03, 2023

Laboratories are focusing on more automated processes while also trying to maintain an efficient, safe, and personalized experience with each analytical test.

A Healthier Tomorrow?

August 02, 2023

Only a significant joint effort across the supply chain will help to make healthcare more sustainable and reduce the impact of climate change on global health.

Phasing Out COVID-19 Regulatory Flexibilities

August 02, 2023

What impact will EMA’s decision to phase out COVID-19 regulatory flexibilities have on the pharma industry?

New Magic from mRNA

August 02, 2023

mRNA may be a modality whose chief advances are yet to come.

Supply Chain Securities

August 02, 2023

Mapping America’s Pharmaceutical Supply (MAPS) Act aims to establish a database including key information about critical drugs so supply chain weaknesses can be identified.

FDA Releases Guidance on Standards Related to Pharmaceutical Quality

August 01, 2023

The program aims to aid submissions from external stakeholders and FDA staff.

Biogen to Acquire Reata Pharmaceuticals for $7.3 Billion

August 01, 2023

Biogen’s acquisition of Reata will grant them access to Reata’s FDA-approved treatment for Friedreich’s ataxia.

AstraZeneca and Pfizer Ink $1 Billion Rare Disease Deal

August 01, 2023

AstraZeneca, via its subsidiary Alexion Pharmaceuticals, will purchase a portfolio of preclinical rare disease gene therapies from Pfizer in a deal worth up to $1 billion.

FDA Guidance on Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals

August 01, 2023

The guidance document outlines recommendations to limit potential carcinogenic risk.